Back to Results
First PageMeta Content
Lymphoma / Histone deacetylase inhibitor / Cutaneous T-cell lymphoma / Romidepsin / Vorinostat / Histone deacetylase / Merck & Co. / Mesothelioma / Targeted therapy / Medicine / Pharmacology / Orphan drugs


Mesothelioma Articles - Merck & Co: Zolinza becomes first app...
Add to Reading List

Document Date: 2010-10-19 13:01:20

Open Document

File Size: 39,24 KB

Share Result on Facebook

Company

Merck & Co / Mesothelioma Articles Merck & Co / Genentech / /

Event

FDA Phase / /

IndustryTerm

pharmaceutical / /

MedicalCondition

cancers / cutaneous T-cell lymphoma patients / non-Hodgkin's lymphoma / cutaneous T-cell lymphoma / mesothelioma / cancer / recurrent disease / /

MedicalTreatment

chemotherapy / /

Organization

FDA / /

Person

Benjamin Friedmann / /

Product

Zolinza / Avastin / Tarceva / /

Technology

chemotherapy / /

URL

http /

SocialTag